Pacira BioSciences, Inc.

DB:82P Stock Report

Market Cap: €778.2m

Pacira BioSciences Future Growth

Future criteria checks 3/6

Pacira BioSciences is forecast to grow earnings and revenue by 59.1% and 0.6% per annum respectively. EPS is expected to grow by 55.3% per annum. Return on equity is forecast to be 5.4% in 3 years.

Key information

59.1%

Earnings growth rate

55.3%

EPS growth rate

Pharmaceuticals earnings growth21.6%
Revenue growth rate0.6%
Future return on equity5.4%
Analyst coverage

Good

Last updated14 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:82P - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026640901441568
12/31/2025646551571818
12/31/2024692-51891338
9/30/2024695-91194204N/A
6/30/202469064185194N/A
3/31/202468270173185N/A
12/31/202367542139155N/A
9/30/20236667130149N/A
6/30/2023669-5127147N/A
3/31/2023669-10105134N/A
12/31/202266716115145N/A
9/30/20226542193126N/A
6/30/202261439102144N/A
3/31/202258038104144N/A
12/31/20215424280126N/A
9/30/20215136298149N/A
6/30/202150317483129N/A
3/31/20214431483983N/A
12/31/20204301463977N/A
9/30/20204211262856N/A
6/30/2020408-101335N/A
3/31/202043505873N/A
12/31/2019421-116071N/A
9/30/201939425866N/A
6/30/201937285364N/A
3/31/201935474455N/A
12/31/201833703449N/A
9/30/2018321-42745N/A
6/30/2018305-11N/A25N/A
3/31/2018292-33N/A15N/A
12/31/2017287-43N/A18N/A
9/30/2017280-51N/A18N/A
6/30/2017281-66N/A33N/A
3/31/2017280-54N/A37N/A
12/31/2016276-38N/A33N/A
9/30/2016273-36N/A33N/A
6/30/2016267-11N/A26N/A
3/31/2016256-3N/A26N/A
12/31/20152492N/A28N/A
9/30/201524110N/A26N/A
6/30/20152314N/A29N/A
3/31/2015219-1N/A30N/A
12/31/2014198-14N/A27N/A
9/30/2014169-31N/A6N/A
6/30/2014141-43N/A-13N/A
3/31/2014111-52N/A-34N/A
12/31/201386-64N/A-44N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 82P is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).

Earnings vs Market: 82P is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 82P is expected to become profitable in the next 3 years.

Revenue vs Market: 82P's revenue (0.6% per year) is forecast to grow slower than the German market (5.6% per year).

High Growth Revenue: 82P's revenue (0.6% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 82P's Return on Equity is forecast to be low in 3 years time (5.4%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y